Trump’s One Big Beautiful Bill Act Darkens Outlook for Government-Backed Clinics
Bluestem Health, a clinic that serves low-income and uninsured patients in Lincoln, Nebraska, has lost…
Bluestem Health, a clinic that serves low-income and uninsured patients in Lincoln, Nebraska, has lost money for the last two years. And CEO Brad Meyer fears times will soon get worse for the clinic and its 21,000 patients. That’s because Nebraska is set to become the first state to require certain Medicaid enrollees to work…
Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. ‘The Federal Government’s Loss Is the County’s Gain’ I wanted to thank Rachana Pradhan and Katheryn Houghton for their coverage of the loss of staff at the National Institutes of Health…
Suki is one of the original Ambient scribing, now Ambient intelligence, companies. They’re selling both to providers and to other partners using their tech in their tools and services (think telehealth, other EHR providers like Athena, and more). Kevin Wang is the Chief Medical Officer, and he told me about the evolution of ambient documentation,…
It is not bringing down US prices, but delaying launches in Europe. Reuters reports: Drug launches in EU markets fell by some 35% in the 10 months since Trump’s executive order, compared with the previous 10 months…Delaying launches at lower EU prices could help secure higher U.S. prices for longer. You can read the full…
March has seen a slew of executive hires, exits and layoffs across the healthcare industry. For instance, Flare Capital Partners, SCAN Group and Advocate Health named new executives. There were also layoffs at organizations including Oracle, Takeda and Blue Shield of California. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared…
Jimini’s $17 million round was from M13, Town Hall Ventures, LionBird, Zetta Venture Partners and OneMind. The post Jimini Health Raises $17M to Scale Clinician-Supervised AI for Behavioral Health appeared first on MedCity News.
Centessa Pharmaceuticals’ cleminorexton is part of the orexin agonist drug class, which could introduce a new approach to the treatment of narcolepsy and other sleep disorders. Acquiring Centessa brings Eli Lilly into a group of clinical-stage orexin agonist drug developers that includes Takeda Pharmaceutical, Alkermes, and Eisai. The post Eli Lilly’s Neuro Prospects Expand to…
By Andy Petrovich, National Vice President, Crothall Healthcare & Afif Eschiek, National Director, Crothall Healthcare Many sterile processing departments manage thousands of reusable devices from thousands of manufacturers, each with its unique reprocessing requirements. Hospitals rely on clear instructions for use (IFUs) to safely reprocess these medical devices. Yet inconsistent or impractical instructions continue to…
Whether AI-driven or legacy applications, the endpoint is the decisive moment. As AI increases in use, having hardware and software that supports a high-performance experience for all staff will improve operational efficiency, patient outcomes, and revenue. The post Healthcare Staff can Maximize the Value of AI with High Performing Endpoints appeared first on MedCity News.
Here are five things providers should know about concussions. The post Concussion Protocols: What Providers Should Know to Diagnose, Treat, and Rehabilitate appeared first on MedCity News.